Skip to main content
Signal8

Tanke Biosciences Corp (TNBI)

Tanke Biosciences Corporation (TNBI) is a company dedicated to the development, production, and sale of a diverse portfolio of animal nutrition and feed additive products through its various subsidiaries. The company organizes its business into four distinct categories: organic trace mineral additives, functional regulation additives, herbal medicinal additives, and other related offerings. Among its product lineup, Tanke Biosciences provides organic trace mineral additives marketed under the Qili brand. It also produces Qilicid feed acidifiers, which are crucial for preventing microbial spoilage of raw ingredients and finished animal feeds. The company's offerings further include various seasonings and Tankeball branded flavor enhancers, designed to act as agents in the creation of blended feeds. For those seeking herbal solutions, Extra-Health, Qilimix, and Recoccider are names associated with its herbal medicinal additives, which are incorporated directly into feed products. Moreover, Tanke Biosciences manufactures and distributes a wide array of trace mineral premix products for livestock and poultry, also under the Qilimix label. Its Tankeball brand extends to natural sweeteners and attractants, specifically formulated for pigs, piglets, fish, and other aquatic animals. Another key product is a water-soluble organic multi-vitamin electrolyte, intended to be dissolved in drinking water for easy animal consumption. The company caters to a broad customer base, encompassing medium to large-scale feed production factories, major livestock operations, and individual farmers. Its products are primarily distributed and sold across the People's Republic of China, Southeast Asia, and Latin America. Tanke Biosciences Corporation was founded in 1989 and maintains its headquarters in Guangzhou, People's Republic of China.

Sector: Grain Mill Products

Industry: Asset Management

Tanke Biosciences Corporation logo

Tanke Biosciences Corporation

OTC:TNBIFinancial Services
Mkt Cap$372K
Float7.94M
O/S13.32M
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$8K
Net Income-$274K
Total Assets$74K
Free Cash Flow-$37K
Debt & Equity
Total Debt$140K
Total Equity-$399K
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in TNBI's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$74K
Liabilities$473K
Accounts Receivable$0
Accounts Payable$304K
Inventory$0
PP&E (Net)$40K
Goodwill$24K
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue$8K$0$0$0$0$28.56M$23.83M$0$0$0$0
YoY Growth-----19.8%-----
Cost of Revenue$2K$978$9K$0$0$18.62M$15.06M$0$0$0$0
Gross Profit$7K-$977-$9K$0$0$9.94M$8.77M$0$0$0$0
Gross Margin81.4%----34.8%36.8%----
Research and Development$0$0$0$0$0$291K$246K$0$0$0$0
Selling, General, and Administrative$265K$116K$86K$128K$668K$5.25M$6.95M$27K$20K$18K$7K
Other$0$0$0$0$0$0$0$0$0$0$0
Total Operating Expenses$265K$116K$86K$128K$668K$5.41M$7.03M$27K$20K$18K$7K
Operating Income (EBIT)-$258K-$117K-$94K-$128K-$668K$4.53M$1.74M-$27K-$20K-$18K-$7K
Operating Margin-3058.9%----15.9%7.3%----
Interest Expense$17K$908$56K$56K$2K$1.45M$1.36M$3K$2K$581$45
Interest Income$0$0$0$0$0$296K$96K$5K$0$0$0
Other Income (Expense)-$17K-$3K$12K$30K-$55K-$3.93M-$4.19M-$3K-$2K-$581-$45
Income Before Tax (EBT)-$274K-$120K-$83K-$98K-$723K$603K-$2.45M-$30K-$22K-$19K-$7K
Income Tax Expense$0$0$0$0$0$832K$681K$0$0$0$0
Net Income-$274K-$120K-$83K-$98K-$723K-$210K-$3.14M-$30K-$22K-$19K-$7K
Net Income Margin-3255.8%-----0.7%-13.2%----
Supplementary Data
EPS-0.01-0.00-0.00-0.01-0.06-0.02-0.24-0.00-0.05-0.05-0.02
Diluted EPS-0.01-0.00-0.00-0.01-0.06-0.02-0.24-0.00-0.05-0.05-0.02
Weighted Average OS25.46M25.46M21.11M12.48M12.75M13.32M13.08M10.76M399,175399,175399,175
EBITDA-$256K-$116K-$18K$0-$53K$5.46M$2.23M-$27K-$20K-$18K-$7K
EBITDA Margin-3040.3%----19.1%9.4%----
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Assets
Current Assets
Cash and Cash Equivalents$6K$0$3K$7K$41K$6.17M$7.7M$0$0$0$0
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$6K$0$3K$7K$41K$6.17M$7.7M$0$0$0$0
Accounts Receivable$0$0$0$0$0$5.36M$4.72M$3.91M$0$0$0
Inventory$0$0$0$0$0$1.41M$1.19M$0$0$0$0
Other Current Assets$0$0$0$0$0$392K$974K$183K$0$0$0
Total Current Assets$11K$0$3K$7K$41K$22.37M$18.91M$0$0$750$0
Long-Term Assets
Property, Plant & Equipment Net$40K$42K$43K$0$0$5.11M$4.81M$0$0$0$0
Goodwill$24K$24K$24K$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$5.36M$838K$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$135K$328K$0$0$0$0
Total Long-Term Assets$64K$66K$66K$0$0$6.48M$5.97M$0$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0
Total Assets$74K$66K$69K$7K$41K$28.85M$24.89M$0$0$750$0
Liabilities
Current Liabilities
Accounts Payable$304K$0$11K$0$0$647K$785K$605K$2K$0$0
Short-Term Debt$140K$140K$140K$53K$2K$8.54M$785K$42K$28K$17K$4K
Current Income Tax Payable$0$0$0$0$0$1.93M$1.33M$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$2.78M$1.52M$0$0$0$0
Other Current Liabilities$29K$91K$14K$42K$100K$696K$645K-$1.4M$0$0$0
Total Current Liabilities$473K$249K$165K$95K$101K$12.1M$3.55M$56K$32K$17K$4K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$793K$5.13M$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$38K$356K$0$0$0$0
Total Long-Term Liabilities$0$0$0$0$0$831K$5.49M$0$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$473K$249K$165K$95K$101K$12.93M$9.03M$56K$32K$17K$4K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0
Common Stock$25K$25K$21K$21K$5K$13K$13K$3K$3K$3K$3K
Retained Earnings-$13.24M-$13.25M-$13.14M-$13.05M-$12.96M$2.49M$2.7M-$111K-$81K-$59K-$41K
Comprehensive Income & Other-$274K$0$0$0$0$1.03M$551K$0$0$0$0
Other Stockholders' Equity$12.82M$13.04M$13.02M$12.95M$12.89M$13.25M$13.14M$51K$45K$39K$33K
Total Equity-$399K-$183K-$96K-$88K-$60K$15.75M$15.85M-$56K-$32K-$17K-$4K
Minority Interest$0$0$0$0$0$171K$0$0$0$0$0
Total Liabilities and Equity$74K$66K$69K$7K$41K$28.68M$24.89M$0$0$750$0
Supplementary Data
Total Debt$140K$140K$140K$53K$2K$9.33M$5.92M$42K$31K$17K$4K
Net Debt$134K$140K$137K$46K-$40K$3.16M-$1.78M$42K$31K$17K$4K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Operating Activities
Net Income-$274K-$120K-$83K-$98K-$723K-$229K-$3.14M$0-$22K-$19K-$7K
Depreciation & Amortization$2K$978$9K$128K$668K$636K$400K$0$0$0$0
Deferred Income Tax$0$0$0$0$0$19K$0$0$0$0$0
Stock-Based Compensation$0$0$0$70$663K$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0-$172K-$170K$0$0$0$0
  Inventory$0$0$0$0$0-$227K$173K$0$0$0$0
  Accounts Payable$224K$67K$11K$0$0-$138K$153K$7K$2K$0$0
  Other Working Capital$12K$17K$9K$3K$2K-$4.74M$323K$3K$750$0$0
Total Working Capital Change$236K$84K$20K$3K$2K-$5.27M$480K$10K$2K-$750$0
Other Non-Cash Items$0$0-$20K-$93K-$613K$3.68M$5.8M-$24K$6K$6K$3K
Net Cash from Operating-$37K-$35K-$75K-$59K-$4K-$1.18M$3.54M-$14K-$13K-$13K-$4K
Investing Activities
Capital Expenditures$0$0$0$0$0-$1.34M-$1.23M$0$0$0$0
Acquisitions$0$0$0$0$0$190K$76K$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0-$861K-$2.93M$0$0$0$0
Net Cash from Investing$0$0$0$0$0-$1.53M-$3.56M$0$0$0$0
Financing Activities
Debt Repaid-------$6.52M----
Common Stock Issuance$43K$4K$0$0$0$0$0$0$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$28K$0$0$45K$475K-$707K-$329K$0$0$0
Net Cash from Financing$43K$32K$70K$25K$45K$1.12M$5.82M$14K$13K$13K$4K
Forex Effect$0$0$0$0$0$58K-$322K$0$0$0$0
Net Change in Cash$6K-$3K-$5K-$34K$41K-$1.53M$5.48M$0$0$0$0
Supplementary Data
Operating Cash Flow-$37K-$35K-$75K-$59K-$4K-$1.18M$3.54M-$14K-$13K-$13K-$4K
Capital Expenditure-$3$0$0-$3$0-$1.34M-$1.23M$0$0$0$0
Free Cash Flow-$37K-$35K-$75K-$59K-$4K-$2.52M$2.31M-$14K-$13K-$13K-$4K
Cash at Beginning$0$3K$7K$41K$0$7.7M$2.22M$0$0$0$0
Cash at End$6K$0$3K$7K$41K$6.17M$7.7M$0$0$0$0